Moreover, CCK-8 assays revealed that up-regulation of MED29 promoted cell proliferation in both A549 and PC9 cells (Fig. 4H, I), whereas knockdown of MED29 inhibited the growth rate of NSCLC cells (Fig. 4J, K). The gene discussed is MED29; the disease is non-small cell lung carcinoma.